metallodrugs

Term used to define a pharmaceutical, having a activity center containing a metal. Platinum (cisplatin, carboplatin) and gold (Auranofin) compounds are well-known in cancer therapy whereas some other gold compounds (aurithiomalate, aurothioglucose) are important antiarthritic drugs. A wide range of Tc compounds (e.g. Tc-labelled antibodies, Tc-mercaptoacetyl glycine complex) are used for diagnostic imaging of renal, cardiac and cerebral functions and of various forms of cancer. Gadolinium (III) polyaminopolycarboxylic crown complexes are widely used as contrast agents in magnetic resonance imaging.



The term "metallodrugs" was found in the following pages:

Toxicity of organomercury compounds | EVISA's News
Brief summary: Speciation analysis for the study of metallodrugs and their biomolecular interactions | EVISA's News
Non-chromatographic separation techniques for speciation analysis | EVISA's News
Liquid-liquid extraction in speciation analysis | EVISA's News
All about Pharmacy and Pharmaceutical Sciences | EVISA's News
Gadolinium speciation analysis in search for the cause of nephrogenic systemic fibrosis (NSF) | EVISA's News
Books and Special Issues on Elemental Speciation (published since 2016) | EVISA's News
Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls | EVISA's News
FDA identifies no harmful effects to date with brain retention of gadolinium-based contrast agents for MRIs | EVISA's News
Link database: Australia: University of Sydney: Group of Peter A. Lay
Speciomics as a concept involving chemical speciation and omics | EVISA's News
Solid-phase extraction in speciation analysis | EVISA's News
Types of Chemical Species | EVISA's News
EMA Issues Final Opinion Limiting Gadolinium Contrast Agents in Body Scans | EVISA's News
Impressions from the 6th Metallomics Symposium | EVISA's News
FDA investigating risk of gadolinium contrast agent brain deposits | EVISA's News
Chemical speciation analysis for life science | EVISA's News
Directory of scientists: Katarzyna Pawlak
Link database: Australia: University of Western Sydney: Biologically Active Drugs by Design Group
The retention of gadolinium in the human body following the use of gadolinium-based MRI contrast agents: a call to action for analytical chemists | EVISA's News